Curbing Unproven Stem Cell-Based “Treatments” episode artwork

EPISODE · Jul 9, 2021 · 41 MIN

Curbing Unproven Stem Cell-Based “Treatments”

from The Stem Cell Report with Janet Rossant

In this episode, Drs. Zubin Master, Kirstin Matthews, Mohamed Abou-el-Enein, and Sean Morrison join the podcast to talk about unproven stem cell-based interventions. These so-called “stem cell therapies” or “regenerative therapies” currently being marketed direct-to-consumers have insufficient evidence of safety and efficacy to justify their use and pose a potential risk to recipients. A recent paper from Masters, Mathews and Abou-el-Enein published in Stem Cell Reports discusses this global public health problem.GuestsMohamed Abou-El-Enein, MD, PhD, MSPH Keck School of Medicine, University of Southern California, USAZubin Master, PhD, Mayo Clinic, USAKirstin Matthews, PhD, Baker Institute for Public Policy, Rice University, USASean Morrison, PhD, Children’s Research Institute, UT Southwestern, USAHostMartin Pera, PhD – Editor-in-Chief, Stem Cell Reports and The Jackson LaboratoryWebsite: https://www.jax.org/research-and-faculty/faculty/martin-peraTwitter: @martinperaJAXSupporting DocumentsUnproven stem cell interventions: A global public health problem requiring global deliberation About Stem Cell ReportsStem Cell Reports is the Open Access journal of the International Society for Stem Cell Research for communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians.About ISSCRWith nearly 4,000 members from more than 65 countries, the International Society for Stem Cell Research is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health.Twitter: @ISSCR AcknowledgementsISSCR StaffKeith Alm, Chief Executive OfficerBethany Almon, Senior Manager of Integrated MarketingYvonne Fisher, Managing Editor, Stem Cell ReportsKym Kilbourne, Director of Media and Strategic CommunicationsJack Mosher, Senior Manager of Scientific AffairsVoice WorkJulie PerlinMusic@Konovalov

Episode metadata supplied by the publisher feed · Published Jul 9, 2021

Embed this episode

In this episode, Drs. Zubin Master, Kirstin Matthews, Mohamed Abou-el-Enein, and Sean Morrison join the podcast to talk about unproven stem cell-based interventions. These so-called “stem cell therapies” or “regenerative therapies” currently being marketed direct-to-consumers have insufficient evidence of safety and efficacy to justify their use and pose a potential risk to recipients. A recent paper from Masters, Mathews and Abou-el-Enein published in Stem Cell Reports discusses this global ...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Curbing Unproven Stem Cell-Based “Treatments”

0:00 41:42

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Stem Cell Report with Janet Rossant?

This episode is 41 minutes long.

When was this The Stem Cell Report with Janet Rossant episode published?

This episode was published on July 9, 2021.

Can I download this The Stem Cell Report with Janet Rossant episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!